In summary, these data indicated an oncogenic role of DLGAP1-AS2 in tumorigenesis and progression of GC and suggested that Six3/Wnt1/β-catenin signaling acted downstream of DLGAP1-AS2 to precisely control this process. This evidence concerns the gene SIX3 and gastric cancer.